Skip to main content

Table 3 LA/Ao-Ratio and LVIDDN of all dogs at the different examination times

From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

Day 0 Day 90 Day 180  
LA/Ao LVIDDN LA/Ao LVIDDN LA/Ao LVIDDN Group
1.22 1.42 1.22 1.57 1.35 1.36 A
1.00 1.73 1.37 1.55 1.39 1.45 A
1.22 1.46 1.33 1.33 1.33 1.37 A
1.15 1.43 1.15 1.26 1.15 1.26 A
0.95 1.41 1.30 0.97 1.18 1.04 A
1.43 1.61 1.22 1.52 1.20 1.42 A
1.11 1.78 1.27 1.81 1.06 2.00 A
1.27 1.60 1.23 1.41 1.53 1.58 A
1.46 1.51 1.32 1.52 1.34 1.59 A
1.35 1.70 1.46 1.63 1.31 1.75 A
1.07 1.65 1.50 1.65 1.51 1.70 B
1.24 1.62 1.11 1.40 1.09 1.63 B
1.30 1.55 1.30 1.67 1.22 1.42 B
1.51 1.76 1.40 1.55 1.70 1.60 B
1.17 1.67 1.47 1.73 1.30 1.72 B
1,28 1.58 1.34 1.40 1.49 1.50 B
1,22 1.56 1.06 1.66 1.40 1.38 B
1,29 1.86 1.13 1.60 1.38 1.79 B
1,30 1.63 1.41 1.42 1.38 1.67 B
1,42 1.34 1.42 1.28 1.25 1.26 B